
Koninklijke Philips N.V. PHG
€ 25.21
3.74%
Geschäftsbericht 2025
hinzugefügt 18.04.2026
Koninklijke Philips N.V. EBITDA per Share 2011-2026 | PHG
EBITDA per Share Jährlich Koninklijke Philips N.V.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 0.61 | 1.37 | 1.48 | 1.85 | 1.63 | 2.37 | 1.52 | 1.02 | 3.65 | 2.99 | 0.754 |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.65 | 0.61 | 1.75 |
EBITDA per Share anderer Aktien in der Diagnostik & Forschung
| Name | EBITDA per Share | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
5.49 | $ 121.87 | 3.06 % | $ 37 B | ||
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 20.67 | -8.13 % | $ 222 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 21.42 | -4.46 % | $ 1.14 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 1.56 | 6.85 % | $ 2.08 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 25.05 | 2.0 % | $ 696 M | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 183.88 | 3.92 % | $ 9.11 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
7.63 | $ 194.75 | 0.5 % | $ 139 B | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 2.0 | -9.09 % | $ 8.85 M | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 5.08 | 1.6 % | $ 470 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
NeoGenomics
NEO
|
-0.62 | $ 8.35 | 2.33 % | $ 1.07 B | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.51 | 2.92 % | $ 2.06 B | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 520.6 | 0.96 % | $ 15 B | ||
|
Illumina
ILMN
|
-3.01 | $ 134.5 | 1.34 % | $ 21.4 B | ||
|
Precipio
PRPO
|
0.03 | $ 28.3 | -2.41 % | $ 45.4 M | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 16.26 | 0.81 % | $ 492 M | ||
|
Guardant Health
GH
|
-3.17 | $ 90.36 | 5.44 % | $ 11.3 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 6.77 | - | $ 282 M | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-361 | $ 2.91 | 2.83 % | $ 94.4 K | ||
|
Soleno Therapeutics
SLNO
|
0.22 | $ 52.78 | 0.4 % | $ 2.68 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.18 | -0.91 % | $ 5.01 M | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 119.68 | 3.55 % | $ 9.87 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 270.68 | 1.62 % | $ 22.5 B | ||
|
Neuronetics
STIM
|
-0.42 | $ 1.42 | 1.43 % | $ 93.7 M | ||
|
Celcuity
CELC
|
-3.68 | $ 122.46 | -2.23 % | $ 5.73 B | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 83.82 | -0.12 % | $ 5.66 B | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 526.6 | 2.05 % | $ 199 B | ||
|
Trinity Biotech plc
TRIB
|
0.08 | $ 0.75 | 6.62 % | $ 61.9 M | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 195.02 | 1.86 % | $ 21.6 B | ||
|
ENDRA Life Sciences
NDRA
|
-7.27 | $ 6.4 | 23.79 % | $ 5.04 M |